RenovoRx CFO granted 80,000-share stock award
VOLL MARK reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
VOLL MARK reported acquisition or exercise transactions in this Form 4 filing.
RenovoRx, Inc. reported that Chief Financial Officer Mark Voll received an award of 80,000 shares of Common Stock on April 3, 2026, reflecting stock-based compensation rather than an open-market purchase. The award stems from grants of restricted stock units for his service as CFO.
The footnote explains this consists of 8,777 RSUs for February 2026, 12,270 RSUs for March 2026, and 58,953 RSUs for future service, with the February and March RSUs fully vested upon grant and the remainder vesting monthly. After the transaction, he holds 117,380 shares directly and 97,200 shares indirectly through the Voll Family Trust.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 80,000 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. The reported transaction involved the Reporting Person's receipts of (i) a grant of 8,777 restricted stock units ("RSUs") for his service as the Chief Financial Officer of the Issuer for February 2026, which are fully vested upon grant, and (ii) a grant of 12,270 RSUs for his service as the Chief Financial Officer for March 2026, which are fully vested upon grant and (iii) a grant of 58,953 RSUs for his future service as the Chief Financial Officer of the Issuer, subject to monthly vesting with the RSUs valued based on the closing price on the last trading day of the month in which the services were performed.
Key Figures
Key Terms
restricted stock units ("RSUs") financial
fully vested upon grant financial
monthly vesting financial
closing price on the last trading day of the month financial
Voll Family Trust DTD 6/23/2010 Mark Voll TTEE financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did RenovoRx (RNXT) CFO Mark Voll report in this Form 4?
What vesting terms apply to the RenovoRx (RNXT) CFO’s RSU awards?
What indirect ownership does the RenovoRx (RNXT) CFO disclose in this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.